A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing
Science · 29.11.2024 · 386 (6725) · 1010-1018
DOI: 10.1126/science.adp3025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 29.11.2024. Verfasst von Ge Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber/Boston Children's Hospital Cancer and Blood Disorder Center, Department of Pediatrics, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Erythroid Cells, Fetal Hemoglobin, gamma-Globins, Protein Multimerization. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Down-regulation of BCL11A protein reverses the fetal (HbF, α 2 γ 2 ) to adult (HbA, α 2 β 2 ) hemoglobin switch and is exploited in gene-based therapy for hemoglobin disorders. Because of reliance on ex vivo cell manipulation and marrow transplant, such therapies cannot lessen disease burden. To develop new small-molecule approaches, we investigated the state of BCL11A protein in erythroid cells. We report that tetramer formation mediated by a single zinc finger (ZnF0) is required for production of steady-state protein. Beyond its role in protein stability, the tetramer state is necessary for γ-globin gene repression, because an engineered monomer fails to engage a critical co-repressor complex. These aspects of BCL11A protein production identify tetramer formation as a vulnerability for HbF silencing and provide opportunities for drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dana-Farber/Boston Children's Hospital Cancer and Blood Disorder Center, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
- Lester Sue Smith Breast Center, Department of Human Molecular Genetics, Baylor College of Medicine, Houston, TX, USA.
- Howard Hughes Medical Institute, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Ge Zheng, Maolu Yin, Stuti Mehta, I-Te Chu, Stacy Wang, Alia AlShaye, Karin Tenglin, Stuart H Orkin
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- Howard Hughes Medical Institute
Zitieren
APA
Zheng, G., Yin, M., Mehta, S., Chu, I. T., Wang, S., AlShaye, A., Drainville, K., Buyanbat, A., Bienfait, F., Tenglin, K., Zhu, Q., & Orkin, S. H. (2024). A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing. Science, 386(6725), 1010-1018. https://doi.org/10.1126/science.adp3025
Vancouver
Zheng G, Yin M, Mehta S, Chu IT, Wang S, AlShaye A, et al. A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing. Science. 2024;386(6725):1010-1018. doi:10.1126/science.adp3025
BibTeX
@article{Zheng2024,
author = {Zheng, Ge and Yin, Maolu and Mehta, Stuti and Chu, I-Te and Wang, Stacy and AlShaye, Alia and Drainville, Kirstin and Buyanbat, Altantsetseg and Bienfait, Frédérique and Tenglin, Karin and Zhu, Qian and Orkin, Stuart H},
title = {A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing},
journal = {Science},
year = {2024},
volume = {386},
number = {6725},
pages = {1010--1018},
doi = {10.1126/science.adp3025}
}
EUVIMED